| Literature DB >> 3867402 |
J H Scarffe, J B Kenny, R J Johnson, S E Owens, G R Giles, S H Leveson, W V Maley.
Abstract
Patients with advanced inoperable or recurrent adenocarcinoma of the stomach received an iv bolus of epirubicin (75 mg/m2) every 3 weeks. Partial responses were observed in four of 24 evaluable patients (17%). Treatment was generally well tolerated; a drop in left ventricular ejection fraction was observed in one patient who had received 450 mg/m2 of epirubicin.Entities:
Mesh：
Substances：
Year: 1985 PMID： 3867402
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960